News and Opinions Archives - Page 5 of 26

World Stem Cell Summit-CHINA and Phacilitate Leaders Asia taking place, October 15-16, at the Kerry Hotel Pudong Shanghai

by admin | Sep 17, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Dear Colleagues, For 16 years, I have been engaged in creating trans-disciplinary conferences aimed at advancing regenerative medicine, stem cell research and advanced therapies. The overarching mission is to improve health and deliver cures. We all know that this is...

Join Us: Sept 19 Congressional Lunch Briefing on Regenerative Cell Therapies

by admin | Sep 16, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Addressing the problem of “bad actors”! Regenerative Medicine Foundation and Alliance for Cell Therapy NOW organize educational briefing for U.S. House and Senate – Washington, D.C. September 19th 12pm – 1:30pm ET (lunch will be served) at 902 Hart Senate Office...

Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function

by admin | Sep 12, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

DURHAM, N.C. (PRWEB)September 10, 2019 – A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs). Importantly, while several previous...

At last! Google policy bars ads for unproven stem cell and gene therapies – acknowledges “good actors”

by admin | Sep 9, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

September 6, 2019 – Digital advertising helps fuel an open internet for people all over the world — allowing billions of people to ask questions, find answers, and discover new ideas. We know the digital ads ecosystem can only flourish if it’s a place that...

Study shows stem cells may be better choice than tissue transplantation for treating LSCD

by admin | Sep 5, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Durham, NC – Results of a phase II clinical trial released today in STEM CELLS Translational Medicine (SCTM) indicate that a limbal stem cell (LSC) transplantation is superior to a tissue graft in treating limbal stem cell deficiency syndrome (LSCD). This could result...

FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products that may put patients at risk; continues to warn patients of the risk of unapproved stem cell therapy

by admin | Sep 4, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Stemell sold stem cell products without required FDA approval The U.S. Food and Drug Administration has warned Stemell, Inc. (Stemell), of San Juan Capistrano, California, and its president and Chief Executive Officer, Peyman Taeidi, Ph.D., for manufacturing and...